Apt Therapeutics

Transforming human apyrase into life-saving medicine for thrombotic diseases

placeSt. Louis, Missouri, United States calendar_todayFounded 2001 groups2 employees language apt-therapeutics.com

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital250%
Private equity125%
Other / undisclosed125%
Coming soon